H.R. 9586 — Introduced in House

I 118th CONGRESS 2d Session H. R. 9586 IN THE HOUSE OF REPRESENTATIVES September 12, 2024Mr. Steube (for himself, Mr. Reschenthaler, Mr. Weber of Texas, Mr. Duncan, Mr. LaMalfa, Mr. Tiffany, and Mr. Rosendale) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To prohibit Federal funds from being used to provide certain gender transition procedures to individuals in the custody of the Department of Homeland Security and the Department of Health and Human Services. 1. Short title This Act may be cited as the Stopping Transgender Operation Payments and Wacky Expenses for Illegal Residents and Detainees Act of 2024 or the STOP WEIRD Act of 2024. 2. Prohibiting federal funds from being used to provide certain gender transition procedures (a) In general Notwithstanding any other provision of law, no Federal funds may be used or otherwise made available to provide or refer for a specified gender transition procedure to an individual in the custody of the Department of Homeland Security or the Department of Health and Human Services or to reimburse any entity for providing such a procedure to such an individual. (b) Specified gender transition procedure defined (1) In general For purposes of this paragraph, except as provided in paragraph (2), the term specified gender transition procedure means, with respect to an individual, any of the following when performed for the purpose of intentionally changing the body of such individual to no longer correspond to their sex: (A) Performing any surgery, including— (i) castration; (ii) orchiectomy; (iii) scrotoplasty; (iv) vasectomy; (v) hysterectomy; (vi) oophorectomy; (vii) ovariectomy; (viii) metoidioplasty; (ix) penectomy; (x) phalloplasty; (xi) vaginoplasty; (xii) vaginectomy; (xiii) vulvoplasty; (xiv) reduction thyrochondroplasty; (xv) chondrolaryngoplasty; (xvi) mastectomy; and (xvii) any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other body features of an individual. (B) Any placement of chest implants to create feminine breasts. (C) Any placement of fat or artificial implants in the gluteal region. (D) Administering, supplying, prescribing, dispensing, distributing, or otherwise conveying to an individual medications, including— (i) gonadotropin-releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty; and (ii) testosterone, estrogen, or other androgens to an individual at doses that are supraphysiologic than would normally be produced endogenously in a healthy individual of the same age and sex. (2) Sex For purposes of paragraph (1), the term sex means the indication of male or female sex by reproductive potential or capacity, sex chromosomes, naturally occurring sex hormones, gonads, or internal or external genitalia present at birth.